Back

Select your region

Arrange a consultation about stem cells

Learn more

List of
transplantations

List of uses for stem cells approved by the FamiCord Group’s laboratories:

Image
List of uses for stem cells approved by the FamiCord Group’s laboratories:
Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
3001 Apheresis Allogeneic Beta Thalassemia Major Hematology 2022 Standard Therapy Poland 11
3002 Apheresis Allogeneic C-All Rez (Acute Lymphoblastic Leukemia) Hematology 2022 Standard Therapy Poland 66
3003 Apheresis Allogeneic C-All Rez (Acute Lymphoblastic Leukemia) Hematology 2022 Standard Therapy Poland 5
3004 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2022 Standard Therapy Poland 3
3005 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2022 Standard Therapy Poland 3
3006 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2022 Standard Therapy Poland 5
3007 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2022 Standard Therapy Poland 63
3008 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2022 Standard Therapy Poland 59
3009 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2022 Standard Therapy Germany 58
3010 Apheresis Allogeneic Chronic Lymphocytic Leukemia Richter Transformation 7/22 Hematology 2022 Standard Therapy Poland 44
3011 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2022 Standard Therapy Poland 64
3012 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2022 Standard Therapy Poland 67
3013 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2022 Standard Therapy Poland 63
3014 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2022 Standard Therapy Poland 59
3015 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2022 Standard Therapy Poland 64
3016 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2022 Standard Therapy Poland 60
3017 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 70
3018 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 54
3019 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 63
3020 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 54
3021 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 71
3022 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 67
3023 Apheresis Allogeneic Chronic Myelomonocytic Leukemia, Type 0 (Cmml-0) Hematology 2022 Standard Therapy Poland 64
3024 Apheresis Allogeneic Chronic Neutrophilic Leukemia Hematology 2022 Standard Therapy Poland 66
3025 Apheresis Allogeneic Chronic Neutrophilic Leukemia Hematology 2022 Standard Therapy Poland 72
3026 Apheresis Allogeneic Combined Immunodeficiency Syndrome With Hyper-Igm Hematology 2022 Standard Therapy Poland 6
3027 Apheresis Allogeneic Congenital Dyserythropoietic Anemia Hematology 2022 Standard Therapy Poland 2
3028 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 68
3029 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 65
3030 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 69
3031 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 50
3032 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 56
3033 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 65
3034 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 47
3035 Apheresis Autologous Diffuse Large B-Cell Lymphoma – Relapse Hematology 2022 Standard Therapy Germany 66
3036 Apheresis Autologous Diffuse Large B-Cell Lymphoma With Cerebral Acute Lymphoblastic Leukemia Hematology 2022 Standard Therapy Germany 66
3037 Apheresis Autologous Germ Cell Tumor Hematology 2022 Standard Therapy Germany 39
3038 Apheresis Autologous Germ Cell Tumor Hematology 2022 Standard Therapy Germany 33
3039 Apheresis Allogeneic Hemophagocytic Lymphohistiocytosis (Hlh) Hematology 2022 Standard Therapy Poland 12
3040 Apheresis Allogeneic Hemophagocytic Lymphohistiocytosis (Hlh) Hematology 2022 Standard Therapy Poland 21
3041 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 26
3042 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 31
3043 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 53
3044 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 25
3045 Apheresis Autologous Hodgkin Lymphoma Hematology 2022 Standard Therapy Germany 67
3046 Apheresis Autologous Hodgkin Lymphoma-Relapse Hematology 2022 Standard Therapy Germany 69
3047 Apheresis Autologous Hodgkin Lymphoma-Relapse Hematology 2022 Standard Therapy Germany 48
3048 Apheresis Allogeneic Hypoplastic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 26
3049 Apheresis Allogeneic Immunodeficiency Hematology 2022 Standard Therapy Poland 3
3050 Apheresis Allogeneic Juvenile Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 5
3051 Apheresis Autologous Mantle Cell Lymphoma Hematology 2022 Standard Therapy Germany 64
3052 Apheresis Autologous Mantle Cell Lymphoma Hematology 2022 Standard Therapy Germany 61
3053 Apheresis Autologous Mantle Cell Lymphoma Hematology 2022 Standard Therapy Germany 52
3054 Apheresis Autologous Mantle Cell Lymphoma Hematology 2022 Standard Therapy Germany 44
3055 Apheresis Autologous Mantle Cell Lymphoma Hematology 2022 Standard Therapy Germany 53
3056 Apheresis Autologous Mantle Cell Lymphoma Hematology 2022 Standard Therapy Germany 49
3057 Apheresis Autologous Mantle Cell Lymphoma Hematology 2022 Standard Therapy Germany 64
3058 Apheresis Allogeneic Mixed Phenotype Acute Leukemia Hematology 2022 Standard Therapy Poland 64
3059 Apheresis Autologous Morbus Hodgkin Hematology 2022 Standard Therapy Germany 36
3060 Apheresis Autologous Morbus Hodgkin Hematology 2022 Standard Therapy Germany 62
3061 Apheresis Autologous Morbus Hodgkin-Relapse Hematology 2022 Standard Therapy Germany 63
3062 Apheresis Allogeneic Mucopolysaccharidosis Hematology 2022 Standard Therapy Poland 2
3063 Apheresis Allogeneic Mucopolysaccharidosis Type I Hematology 2022 Standard Therapy Poland 3
3064 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 58
3065 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 53
3066 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 57
3067 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 64
3068 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 50
3069 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 67
3070 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 55
3071 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 73
3072 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 63
3073 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 65
3074 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 58
3075 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 37
3076 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 47
3077 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 68
3078 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 53
3079 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 60
3080 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 60
3081 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 47
3082 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 59
3083 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 64
3084 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 59
3085 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 52
3086 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 73
3087 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 68
3088 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 63
3089 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 66
3090 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 50
3091 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 69
3092 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 57
3093 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 55
3094 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 61
3095 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 64
3096 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 71
3097 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 61
3098 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 62
3099 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 60
3100 Apheresis Autologous Multiple Myeloma Hematology 2022 Standard Therapy Germany 33